Literature DB >> 19945549

Chemical modification of lysine residues in lysozyme may dramatically influence its amyloid fibrillation.

Dina Morshedi1, Azadeh Ebrahim-Habibi, Ali Akbar Moosavi-Movahedi, Mohsen Nemat-Gorgani.   

Abstract

Studies on the aggregation of mutant proteins have provided new insights into the genetics of amyloid diseases and the role of the net charge of the protein on the rate, extent, and type of aggregate formation. In the present work, hen egg white lysozyme (HEWL) was employed as the model protein. Acetylation and (separately) citraconylation were employed to neutralize the charge on lysine residues. Acetylation of the lysine residues promoted amyloid formation, resulting in more pronounced fibrils and a dramatic decline in the nucleation time. In contrast, citraconylation produced the opposite effect. In both cases, native secondary and tertiary structures appeared to be retained. Studies on the effect of pH on aggregation suggested greater possibilities for amorphous aggregate formation rather than fibrillation at pH values closer to neutrality, in which the protein is known to take up a conformation more similar to its native form. This is in accord with reports in the literature suggesting that formation of amorphous aggregates is more favored under relatively more native conditions. pH 5 provided a critical environment in which a mixture of amorphous and fibrillar structures were observed. Use of Tango and Aggrescan software which describe aggregation tendencies of different parts of a protein structure suggested critical importance of some of the lysine residues in the aggregation process. Results are discussed in terms of the importance of the net charge in control of protein-protein interactions leading to aggregate formation and possible specific roles of lysine residues 96 and 97. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945549     DOI: 10.1016/j.bbapap.2009.11.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Diffusion and sedimentation interaction parameters for measuring the second virial coefficient and their utility as predictors of protein aggregation.

Authors:  Atul Saluja; R Matthew Fesinmeyer; Sabine Hogan; David N Brems; Yatin R Gokarn
Journal:  Biophys J       Date:  2010-10-20       Impact factor: 4.033

2.  Kinetics of surfactant-induced aggregation of lysozyme studied by fluorescence spectroscopy.

Authors:  Neha Jain; Mily Bhattacharya; Samrat Mukhopadhyay
Journal:  J Fluoresc       Date:  2010-10-16       Impact factor: 2.217

3.  Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation.

Authors:  Thomas Schrader; Gal Bitan; Frank-Gerrit Klärner
Journal:  Chem Commun (Camb)       Date:  2016-08-22       Impact factor: 6.222

4.  Monitoring insulin aggregation via capillary electrophoresis.

Authors:  Elizabeth Pryor; Joseph A Kotarek; Melissa A Moss; Christa N Hestekin
Journal:  Int J Mol Sci       Date:  2011-12-14       Impact factor: 5.923

5.  The effect of protein acetylation on the formation and processing of inclusion bodies and endogenous protein aggregates in Escherichia coli cells.

Authors:  Dorota Kuczyńska-Wiśnik; María Moruno-Algara; Karolina Stojowska-Swędrzyńska; Ewa Laskowska
Journal:  Microb Cell Fact       Date:  2016-11-10       Impact factor: 5.328

6.  A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity.

Authors:  Christine Xue; Yoon Kyung Lee; Joyce Tran; Dennis Chang; Zhefeng Guo
Journal:  R Soc Open Sci       Date:  2017-08-09       Impact factor: 2.963

7.  Computational Assessment of Bacterial Protein Structures Indicates a Selection Against Aggregation.

Authors:  Anita Carija; Francisca Pinheiro; Valentin Iglesias; Salvador Ventura
Journal:  Cells       Date:  2019-08-08       Impact factor: 6.600

8.  Study of the mechanism of environmentally friendly translucent balsa-modified lysozyme dressing for facilitating wound healing.

Authors:  Daijun Zhou; Tao Yang; Wei Qian; Malcolm Xing; Gaoxing Luo
Journal:  Int J Nanomedicine       Date:  2018-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.